Cytiva has accomplished an growth of its Logan, UT, facility that successfully doubles its liquid media manufacturing capability, a challenge designed to assist provide chain continuity for patrons counting on the corporate for his or her cell tradition wants.
The corporate has accomplished its animal-derived component-free (ADCF) liquid media growth facility (A1X), Pierre-Alain Ruffieux, Cytiva group government, bioprocess, informed GEN in an interview performed from the corporate’s sales space in the course of the Biotechnology Innovation Group (BIO) Worldwide Conference not too long ago held in San Diego. He mentioned the completion was celebrated with a ceremony on the location.
Cytiva detailed the growth challenge in a Might 12 publish on its web site: The ADCF liquid media growth facility (A1X) has bigger mixing tanks than the present facility, supporting batch sizes from 700 L as much as 13,000 L—in contrast with batch sizes of 100 L to 10,000 L supported by Cytiva’s present facility.
Additionally, the A1X facility makes use of mixing tanks and liquid media switch traces comprised of AL6XN and 316 L stainless-steel. This differs from the present facility tools, which is comprised solely of 316 L stainless-steel. AL6XN is a low-carbon, high-purity stainless-steel alloy that’s extra immune to put on and corrosion than 316 L, representing an improve to the product contact layer versus the present facility tools.
The expanded web site’s added liquid capability comes from the addition of three manifold fill traces, three filling manifolds, six mixing tanks, six formulation cubicles, and a utility constructing to assist massive quantity liquid media manufacturing. Housed within the utility constructing are a forty five,000 L tank and course of water system, a 55,000 L tank and water for injection system, a clear steam generator, and extra supporting utilities.
“Along with the added capability, Cytiva has up to date a number of features of the manufacturing ground format and tools, enhancements designed to shorten manufacturing cycle time, enhance security, and reduce product danger,” the corporate defined. “The updates additionally set up closed methods for cleansing and a managed setting for the transport and dealing with of uncooked supplies and completed items.”
Beforehand, Cytiva accomplished increasing its dry powder and liquid media manufacturing capability for large-volume clients and added high-speed bottle filling for smaller-volume customers. The corporate additionally opened an expanded staging space for completed items, in addition to a brand new centralized 10,000-square-foot high quality management lab to assist elevated manufacturing.
AI’s “two main impacts”
Throughout a wide-ranging interview, Ruffieux mentioned Cytiva’s method to AI and a number of other current Cytiva bulletins.
“We see two main impacts from AI on what we’re doing,” Ruffieux defined. “The primary one, and I at all times like to start out with the purchasers as a result of it’s actually our focus: We see our clients accelerating and growing the variety of targets they’re doing. AI helps them to have extra targets and in a quicker time,” Ruffieux mentioned. “It’s placing strain on the CMC of us, and I feel it’s the place we play: They ask us to supply revolutionary options to go quicker.”
Cytiva’s concentrate on AI is two-fold, he continued.
“One, we’re growing clever tools which is utilizing AI to be simpler for patrons to make use of and that are extra practical; that’s one side. It’s additionally delivering extra expertise in a shorter timeframe,” Ruffieux mentioned. “It’s a form of subsequent stage of DoE [design of experiments], nevertheless it’s additionally delivering a productiveness side as a result of the purpose is to have tools which requires both fewer folks or fewer folks with much less particular information of the tools.”
Like a rising variety of corporations in and out of doors biopharma, Ruffieux mentioned, Cytiva has absolutely embraced AI “to make our product higher, to make the shopper expertise higher, but in addition to enhance our inside processes.”
“Sooner and higher”
“We see AI serving to us to develop software program, writing new software program to go quicker and higher. AI could be very highly effective for reviewing paperwork and doing issues,” he defined. “It’s wonderful what we will do each in writing code, but in addition maybe as importantly, as we validate the code and we check all the pieces, using AI is permitting our folks to work in a way more complete manner, in a a lot quicker manner.”
AI additionally provides a layer, he mentioned, to the continual enchancment ethos that Cytiva and different Danaher-owned corporations apply by way of the Danaher Enterprise System (DBS). For the reason that mid-Nineteen Eighties, Danaher has carried out an ongoing company-wide Kaizen or steady enchancment effort primarily based on lean manufacturing and anchored on DBS, a typical tradition and working system centered on folks, plans, processes, and efficiency.
“AI is an extra pillar to this method, actually serving to the corporate to be extra environment friendly and to drive enterprise,” Ruffieux mentioned.
Cytiva’s clients, he continued, haven’t particularly requested about AI. So what are clients telling the corporate that they need?
“What clients need is Cytiva delivering options which assist them to innovate, produce medication, and speed up these processes. And AI is among the attributes, however they don’t have a selected activity on AI,” Ruffieux replied. “In discussing with senior clients, individuals are within the final result, not within the product itself. So it’s not AI for AI, it’s AI for a enterprise final result. And in life science, the enterprise final result is high quality. It’s reliability. It’s pace. It’s clients asking, can we assist them to be higher?”
AMT designation
Final month, Cytiva hailed the FDA’s granting its Superior Manufacturing Know-how (AMT) designation to the corporate for its Elevecta™ transient cell line for adeno-associated virus (AAV) manufacturing, one of many first gene remedy manufacturing applied sciences to obtain the designation. Prospects utilizing the Elevecta transient cell line will profit, based on Cytiva, from a transparent, predictable regulatory and high quality framework for gene remedy growth.
By its AMT designation, the FDA acknowledges drug manufacturing applied sciences that it deems to have elevated the reliability, high quality, and robustness of superior therapeutics manufacturing. By enabling a streamlined Chemistry, Manufacturing, and Controls (CMC) evaluate and frequent communication with the FDA, designees rely on the AMT designation to assist speed up their manufacturing-related growth timelines and create a significant benefit by way of quicker time to market.
“This recognition by the FDA is giving confidence and belief for our clients: In the event that they use this cell line to supply AAV, they know that the company has seen the technical benefit and it’s confidence on the regulatory pathway,” Ruffieux mentioned. “This recognition by that regulatory physique is giving belief to the work of the corporate in serving to clients develop medication, which is actually the place we place ourselves as true companions.”
Elevecta is designed to considerably scale back the formation and encapsidation of host cell DNA (hcDNA).
“What is gorgeous with that’s, we get a discount of 99% of the host cell DNA. You don’t have to fret any extra in regards to the host cell DNA which is coming along with your product. Once more, that could be a big benefit for the shopper utilizing that,” Ruffieux mentioned. “That is the form of innovation we’re actually proud to carry to our clients.”
Working from hubs in Marlborough, MA, Amersham, U.Ok., Uppsala, Sweden, and Shanghai, Cytiva is a unit of Danaher that was re-launched in 2020 after Danaher spent $21.4 billion for the previous biopharma enterprise of GE Healthcare Life Sciences. Danaher oversees a world household of greater than 20 working corporations centered on biotech and life sciences, in addition to diagnostics, water high quality, and product identification.
Bringing “the whole workflow”
Earlier this month, the corporate mentioned that eight of its 2,000 L single-use Xcellerex bioreactors had been amongst tools contained within the new GMP-2 manufacturing facility inaugurated in Wuhan, China, by Chime Biologics, a decade-long buyer that has used tools made by Cytiva and its predecessor firm.
“I need to put that in a bigger context: At Cytiva, we actually carry to the purchasers the whole workflow, which is actually thrilling for small to mid-sized clients. Coming to us, they actually get a full facility that’s working, actually, from A−Z,” Ruffieux mentioned. “It’s ranging from an growth of the cell line, to freezing the drug substance. It’s a couple of absolutely built-in resolution that helps the shopper to have that. And we have now a number of services like that, that we’re constructing yearly for patrons the world over.”
“We make important investments to have the ability to provide our clients with what they want into totally different areas, in-region-for-region,” Ruffieux mentioned.
In-region-for-region refers to Cytiva’s ongoing effort to fulfill buyer demand for manufacturing instruments and companies usable inside their areas of the world.
“That is actually serving to us and the shopper to safe provide impartial of any disruption,” he added. “Since COVID-19, we have now seen a number of disruptions worldwide. And actually, our unique presence is giving confidence to clients that they may get what they want, impartial of no matter disaster is occurring the world over.”
Worldwide, the US and European Union have championed “reshoring” efforts by drug builders and instruments/expertise suppliers throughout biopharma to fabricate extra of their merchandise inside their areas moderately than in China or elsewhere in Asia.
“When there may be funding, it’s positively at all times a tailwind,” Ruffieux mentioned. “We welcome funding, and we’re comfortable to assist all clients to place up new services, and for the chance these services provide to place our tools.”
